David Pendarvis

David Pendarvis is a declared insider at 3 companies (board member); the most frequent names are ResMed Inc, WD 40 Co and Sequenom Inc. We count 47 filings; the first trade dates from 4 January 2016 and the latest from 5 February 2026.

On the open market, the record shows 3 purchases worth €249k and 29 sales worth €8.4M. The amount is not disclosed for 3 filings. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 12 share grants and 3 option exercises. Since January 2026: 1 purchase and no sales on the market.

Half of the purchases are above €89k and half below. 1 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The latest filing, published on 6 February 2026, reports an open-market purchase of €89k in WD 40 Co. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.